A comprehensive view of Gene Therapy & Regenerative Medicine. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Bayer AG spearheads advanced agricultural initiatives and cell and gene therapy innovations for global impact

Regenerative medicine market expected to grow from US$16.0B in 2023 to US$49.0B by 2028 and grow at a CAGR of 25.1% from 2023-2028; market is segmented into gene therapy, cell therapy and tissue engineering products: MarketsandMarkets

Cencora Spearheads Industry Progress with a Strategic Focus on ESG Commitment and Enhancing Cell and Gene Therapy Accessibility

Cencora's FormularyDecisions platform provides centralized resource for healthcare payers to access info on cell and gene therapy products; the platform seeks to facilitate decision-making on coverage for these therapies

Cencora’s FormularyDecisions Launches Payer Resource for Cell and Gene Therapy Products

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count